Table 5:
Italy | Belgium | Finland | Sweden | Netherlands | |
---|---|---|---|---|---|
Screening frequency, years | 4–7a | 4 | 4 | 2 | 4 |
PSA threshold | 3 ng/ml | 3 ng/ml | 4 ng/ml | 3 ng/ml | 3 ng/ml |
False-positive rate, % | 10.5 | 11.0 | 13.0 | 22.3 | 26.1 |
Abbreviations: ERSPC, European Randomized Study of Screening for Prostate Cancer; PSA, prostate specific antigen.
Screening frequency was 7 years initially, then 4 years.
Source: Kilpelainen et al, 2011. (74)